文献速递类风湿关节炎

类风湿关节炎患者的肺癌风险及其与自身抗体阳性和吸烟的关系

Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking.
PubMed 文献 · RMD Open · 2022-01-01

在瑞典登记库与EIRA早发类风湿关节炎研究中开展人群队列研究,纳入44 101例类风湿关节炎患者和216 495名个体匹配的一般人群参照者,于1995—2018年前瞻性随访肺癌发生。类风湿关节炎患者肺癌发生率为每10万人56例,一般人群参照者为每10万人33例,粗HR(95%CI)为1.76(1.60~1.93);在校正吸烟的子集分析中风险仍升高(HR 1.77,95%CI 1.06~2.97)。血清阳性是类风湿关节炎患者肺癌的显著危险因素,即使校正吸烟后仍使发病率增加2~6倍。

要点

  • 类风湿关节炎患者肺癌粗HR(95%CI)为1.76(1.60~1.93),高于一般人群参照者。
  • 校正吸烟后类风湿关节炎患者肺癌风险仍升高,HR 1.77(95%CI 1.06~2.97)。
  • 血清阳性类风湿关节炎患者在校正吸烟后肺癌发病率增加2~6倍。

核心结论

  • 血清阳性类风湿关节炎是肺癌的危险因素,其作用超出吸烟所能解释的范围,但吸烟或其他气道暴露的残余混杂不能正式排除。
  • 需要提高认识,并可能需要在至少一部分类风湿关节炎患者中开展定期肺癌筛查。

研究设计与样本

  • 基于瑞典登记库和流行病学调查类风湿关节炎(EIRA)早发类风湿关节炎研究的人群队列研究,患者与一般人群参照者按个体匹配。
  • 纳入44 101例类风湿关节炎患者(590例新发肺癌,每10万人56例)和216 495名匹配的一般人群个体(1691例新发肺癌,每10万人33例),1995—2018年前瞻性随访肺癌发生。
  • 计算发病率并进行Cox回归估计肺癌的HR及95%CI,分析中考虑吸烟和类风湿关节炎血清状态。

主要发现

  • 类风湿关节炎患者与一般人群参照者相比,肺癌粗HR(95%CI)为1.76(1.60~1.93)。
  • 在校正吸烟的子集分析中,类风湿关节炎患者肺癌风险仍升高,HR 1.77(95%CI 1.06~2.97)。
  • 与从不吸烟的一般人群个体相比,曾经吸烟的类风湿关节炎患者肺癌风险高出近7倍。
  • 在类风湿关节炎患者中,血清阳性是肺癌的显著危险因素,即使校正吸烟后仍使发病率增加2~6倍。
  • 随访20年时,类风湿关节炎患者总体肺癌风险接近3%,曾经吸烟且至少有1种类风湿关节炎自身抗体的患者超过4%。

关键数值与推荐

  • 类风湿关节炎患者肺癌粗HR(95%CI)为1.76(1.60~1.93)。
  • 校正吸烟的子集分析中类风湿关节炎患者肺癌HR(95%CI)为1.77(1.06~2.97)。
  • 类风湿关节炎患者血清阳性使肺癌发病率增加2~6倍(校正吸烟后仍显著)。
  • 随访20年时类风湿关节炎患者肺癌风险接近3%,曾经吸烟且至少有1种自身抗体的患者超过4%。

临床怎么用

  • 作者认为需要提高对类风湿关节炎患者肺癌风险的认识。
  • 作者认为可能需要在至少一部分类风湿关节炎患者中开展定期肺癌筛查。

局限性

  • 吸烟或其他气道暴露的残余混杂不能被正式排除。
  • 需要在至少一部分类风湿关节炎患者中开展定期肺癌筛查(原文表述为可能有此需要)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Lung cancer is a common malignancy in rheumatoid arthritis (RA). Since smoking is a risk factor for both (seropositive) RA and lung cancer, it remains unclear whether RA, in itself, increases lung cancer risk. METHODS: We performed a population-based cohort study of patients with RA and individually matched general population reference individuals identified in Swedish registers and from the Epidemiological Investigation of RA early RA study, prospectively followed for lung cancer occurrence 1995-2018. We calculated incidence rates and performed Cox regression to estimate HRs including 95% CIs of lung cancer, taking smoking and RA serostatus into account. RESULTS: Overall, we included 44 101 patients with RA (590 incident lung cancers, 56 per 100 000), and 216 495 matched general population individuals (1691 incident lung cancers, 33 per 100 000), corresponding to a crude HR (95% CI) of 1.76 (1.60 to 1.93). In subset analyses, this increased risk remained after adjustment for smoking (HR 1.77, 95% CI 1.06 to 2.97). Compared with general population subjects who were never smokers, patients with RA who were ever smokers had almost seven times higher risk of lung cancer. In RA, seropositivity was a significant lung cancer risk factor, even when adjusted for smoking, increasing the incidence 2-6 times. At 20 years, the risk in patients with RA was almost 3%, overall and over 4% for patients who were ever smokers and had at least one RA autoantibody. CONCLUSIONS: Seropositive RA is a risk factor for lung cancer over and above what can be explained by smoking, although residual confounding by smoking or other airway exposures cannot be formally excluded. There is a need for increased awareness and potentially for regular lung cancer screening, at least in a subset of patients with RA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Chatzidionysiou K, di Giuseppe D, Soderling J, et al. Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking. RMD Open. 2022. PMID: 36270743. doi:10.1136/rmdopen-2022-002465

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。